Strike Pharma
Uppsala
About Strike Pharma
Strike Pharma is using the company’s proprietary Adaptable Drug Affinity Conjugate (ADAC). The company employs an antibody-based technique based on the genetic profile of each patient's tumor that destroys tumor cells while leaving other normal cells alone in the body. The company offers patients a low-cost, effective medication while minimizing the danger of unwanted effects.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Total funding: $6.0M
- Last round: Series Unknown (Feb 2022)
- Website: strikepharma.com
Industries & Categories
Biotechnology, Pharmaceutical, Precision Medicine, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/strike-pharma-31363 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.